Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients

MLA

Aliki Ntzifa, et al. “Gene Expression in Circulating Tumor Cells Reveals a Dynamic Role of EMT and PD-L1 during Osimertinib Treatment in NSCLC Patients.” Scientific Reports, vol. 11, no. 1, Jan. 2021, pp. 1–12. EBSCOhost, https://doi.org/10.1038/s41598-021-82068-9.

APA

Aliki Ntzifa, Areti Strati, Galatea Kallergi, Athanasios Kotsakis, Vassilis Georgoulias, & Evi Lianidou. (2021). Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients. Scientific Reports, 11(1), 1–12. https://doi.org/10.1038/s41598-021-82068-9

Chicago

Aliki Ntzifa, Areti Strati, Galatea Kallergi, Athanasios Kotsakis, Vassilis Georgoulias, and Evi Lianidou. 2021. “Gene Expression in Circulating Tumor Cells Reveals a Dynamic Role of EMT and PD-L1 during Osimertinib Treatment in NSCLC Patients.” Scientific Reports 11 (1): 1–12. doi:10.1038/s41598-021-82068-9.